In This Article:
As global markets navigate through varying economic signals, the Hong Kong market remains a focal point for investors looking for growth opportunities. Amidst this backdrop, companies with high insider ownership in Hong Kong could offer unique advantages, as aligned interests between shareholders and management often drive long-term value creation.
Top 10 Growth Companies With High Insider Ownership In Hong Kong
| Name | Insider Ownership | Earnings Growth |
| iDreamSky Technology Holdings (SEHK:1119) | 20.2% | 104.1% |
| Pacific Textiles Holdings (SEHK:1382) | 11.2% | 37.7% |
| Fenbi (SEHK:2469) | 32.8% | 43% |
| Tian Tu Capital (SEHK:1973) | 34% | 70.5% |
| Adicon Holdings (SEHK:9860) | 22.4% | 28.3% |
| DPC Dash (SEHK:1405) | 38.2% | 90.2% |
| Zylox-Tonbridge Medical Technology (SEHK:2190) | 18.7% | 79.3% |
| Beijing Airdoc Technology (SEHK:2251) | 28.7% | 83.9% |
| Biocytogen Pharmaceuticals (Beijing) (SEHK:2315) | 13.9% | 100.1% |
| Ocumension Therapeutics (SEHK:1477) | 23.1% | 93.7% |
Here we highlight a subset of our preferred stocks from the screener.
Meituan
Simply Wall St Growth Rating: ★★★★★☆
Overview: Meituan is a technology retail company based in the People's Republic of China, with a market capitalization of approximately HK$729.96 billion.
Operations: The company generates its revenue through technology retail operations in China.
Insider Ownership: 11.5%
Meituan has demonstrated robust growth, with a significant 568.2% increase in earnings over the past year and forecasts indicating continued expansion above the Hong Kong market average. Despite substantial insider selling recently, Meituan's strategic moves, including a US$2 billion share repurchase program and corporate governance updates, underscore its proactive management approach. However, trading at 65.8% below estimated fair value suggests potential undervaluation amidst these positive trends.
Arrail Group
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Arrail Group Limited is a healthcare provider specializing in operating dental hospitals and clinics across China, with a market capitalization of approximately HK$1.95 billion.
Operations: The company generates its revenue primarily from two segments: Arrail Dental, which brought in CN¥784.79 million, and Rytime Dental, contributing CN¥960.99 million.
Insider Ownership: 14.9%
Arrail Group has transitioned from a net loss to a profit, with recent earnings showing significant recovery, primarily driven by increased patient visits and operational improvements. While its revenue growth is expected to lag behind the market average at 11.7% per year, earnings are projected to surge by 50.57% annually, outpacing the Hong Kong market's average. Insider transactions have been positive in recent months, indicating confidence from those within the company despite a forecast of low return on equity in three years.